norethindrone has been researched along with Colorectal Neoplasms in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cunningham, SC; Gallmeier, E; Kahn, SR; Kern, SE; Winter, JM | 1 |
Casey, CL; Murray, CA | 1 |
1 review(s) available for norethindrone and Colorectal Neoplasms
Article | Year |
---|---|
HT update: spotlight on estradiol/norethindrone acetate combination therapy.
Topics: Bone Density; Breast Neoplasms; Colorectal Neoplasms; Contraceptives, Oral, Synthetic; Drug Combinations; Endometrial Hyperplasia; Estradiol; Estrogen Replacement Therapy; Female; Humans; Memory; Norethindrone; Norethindrone Acetate; Risk Assessment; Stroke; Venous Thromboembolism | 2008 |
1 other study(ies) available for norethindrone and Colorectal Neoplasms
Article | Year |
---|---|
Novel genotoxicity assays identify norethindrone to activate p53 and phosphorylate H2AX.
Topics: Animals; Cell Cycle; Cell Line, Tumor; Cell Survival; CHO Cells; Colorectal Neoplasms; Comet Assay; Cricetinae; Genes, Reporter; Histones; Humans; Kinetics; Norethindrone; Phosphorylation; Tumor Suppressor Protein p53 | 2005 |